Library

 

Featured

Bruce Smith, Executive Director of Scientific and Medical Strategy, recently spoke with PharmaVOICE on rare disease concierge approaches to patient access.

Clinical Development and Late Stage Research

Observational Studies and Registries | UBC
UBC offers strategic, scientifically rigorous studies designed to address stakeholder-driven evidence requirements. UBC is an industry leader in the design and global implementation of observational...

Reimbursement and Patient Assistance Programs

Bruce Smith, Executive Director of Scientific and Medical Strategy, recently spoke with PharmaVOICE on rare disease concierge approaches to patient access.
Join our comprehensive patient support team at Assembia for a live demo of UBC Pathways™, our proprietary suite of healthcare analytics and technology solutions.

Nursing and Adherence

Join our comprehensive patient support team at Assembia for a live demo of UBC Pathways™, our proprietary suite of healthcare analytics and technology solutions.

Specialty Pharmacy and Distribution

The Orphan Drug Act of 1983 brought increased awareness to the need for new treatments for rare disease patients and provided incentives to pharmaceutical manufacturers of orphan treatments,...